← Back to Clinical Trials
Recruiting NCT07858760

NCT07858760 Study of the Care Pathway of Patients Admitted to the Palliative Care Unit of Strasbourg University Hospital From Their Home in 2025

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07858760
Status Recruiting
Phase —
Sponsor University Hospital, Strasbourg, France
Condition Advanced Chronic Disease
Study Type OBSERVATIONAL
Enrollment 80 participants
Start Date 2026-02-22
Primary Completion 2026-11-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 80 participants in total. It began in 2026-02-22 with a primary completion date of 2026-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Palliative care aims to improve the quality of life of patients with life-threatening illnesses and their families through early identification, assessment, and management of physical, psychosocial, and spiritual needs. The demand for palliative care is steadily increasing due to population aging, the rising prevalence of chronic diseases, and earlier identification of palliative needs. In France, access to palliative care remains insufficient, with only about half of estimated needs currently met. Early integration of palliative care has been shown to improve quality of life, reduce depressive symptoms, and limit aggressive interventions at the end of life, particularly in oncology, with emerging evidence supporting similar benefits in non-cancer chronic diseases. At the same time, healthcare systems face significant pressure, including limited hospital bed capacity and overcrowded emergency departments, highlighting the importance of optimizing care pathways. This retrospective study aims to analyze the care pathways of patients admitted to the palliative care unit of Strasbourg University Hospitals from their home in 2025. It will compare direct admissions to those preceded by an emergency department visit and identify clinical, organizational, and social factors associated with direct admission. The findings are expected to inform strategies to improve access to palliative care, promote home-based management when appropriate, and reduce avoidable emergency department utilization.

Eligibility Criteria

Inclusion Criteria: * Adults aged ≥18 years * Patients admitted to the palliative care unit (UnASP) from home or via the emergency department between January 1, 2025, and December 31, 2025 Exclusion Criteria: * Patients transferred from hospital departments other than the emergency department

Contact & Investigator

Central Contact

Catherine CHEVALIER LAMOUILLE, MD

✉ catherine.lamouille@chru-strasbourg.fr

📞 33 3 3 88 11 65 86

Frequently Asked Questions

Who can join the NCT07858760 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Advanced Chronic Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07858760 currently recruiting?

Yes, NCT07858760 is actively recruiting participants. Contact the research team at catherine.lamouille@chru-strasbourg.fr for enrollment information.

Where is the NCT07858760 trial being conducted?

This trial is being conducted at Strasbourg, France.

Who is sponsoring the NCT07858760 clinical trial?

NCT07858760 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology